Immunogenicity of a psoralen-inactivated dengue virus type 1 vaccine candidate in mice

Ryan C. Maves, Roger M. Castillo Oré, Kevin R. Porter, Tadeusz J. Kochel

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

We evaluated a novel psoralen-inactivated dengue virus type 1 (DENV-1) vaccine candidate in Mus musculus mice. Mice received intradermal alum or 5 to 10 ng of psoralen-inactivated virus. Anti-DENV-1 neutralizing antibody was detectable in 10/11 mice receiving a 10-ng dose at 90 days. Psoralen-inactivated DENV-1 is immunogenic in mice.

Original languageEnglish
Pages (from-to)304-306
Number of pages3
JournalClinical and Vaccine Immunology
Volume17
Issue number2
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Immunogenicity of a psoralen-inactivated dengue virus type 1 vaccine candidate in mice'. Together they form a unique fingerprint.

Cite this